Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders

Selcuk Sozer, Xiaoli Wang, Wei Zhang, Maria Isabel Fiel, Takefumi Ishii, Jiapeng Wang, Nathaniel Wisch, Mingjiang Xu, Ronald Hoffman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The clinical course of patients with Philadelphia chromosome negative myeloproliferative disorder is frequently complicated by thrombotic events. Post-natal vasculogenesis has been proposed to play a critical role in angiogenesis by acting through a hierarchy of endothelial progenitor cells. Some endothelial progenitor cells have been shown to share a number of features associated with monocytes while other more primitive progenitor cells produce endothelial cells in vitro exclusively. The cells which share features of monocytes and endothelial cells have been termed angiogenic monocytes. Reduced levels of angiogenic monocyte progenitor cells have been reported to be predictive of atherosclerotic disease progression. Angiogenic monocyte progenitor cells were assayed in vitro from the peripheral blood mononuclear cells of myeloproliferative disorder patients. Angiogenic monocyte colonies were plucked and analyzed for endothelial cells and hematopoietic cell markers, JAK2V617F and their ability to incorporate into vascular endothelium following their transplantation into non-obese diabetic, severe combine immunodeficient mice. Myeloproliferative disorder angiogenic monocyte colonies that were detected were uniformly JAK2V617F positive and produced cells that expressed phenotypic markers characteristic of both monocytes and endothelial cells. Reduced numbers of angiogenic monocyte colonies were present in the blood of myeloproliferative disorder patients with a high JAK2V617F burden (> 50%), (p <0.01). Transplanted angiogenic monocytes were able to contribute to the vascular endothelium of non-obese diabetic, severe combine immunodeficient mice. These studies suggest that reduced numbers of circulating angiogenic monocyte progenitors contribute to the propensity to develop thrombotic complications in myeloproliferative disorder patients.

Original languageEnglish (US)
Pages (from-to)284-291
Number of pages8
JournalBlood Cells, Molecules and Diseases
Volume41
Issue number3
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Myeloproliferative Disorders
Monocytes
Stem Cells
Alleles
Endothelial Cells
Vascular Endothelium
Philadelphia Chromosome
Disease Progression
Blood Cells
Transplantation

Keywords

  • Angiogenic monocytes
  • Endothelial cell
  • Myeloproliferative disorders
  • Thrombosis
  • Xenotransplant

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Hematology
  • Cell Biology

Cite this

Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders. / Sozer, Selcuk; Wang, Xiaoli; Zhang, Wei; Fiel, Maria Isabel; Ishii, Takefumi; Wang, Jiapeng; Wisch, Nathaniel; Xu, Mingjiang; Hoffman, Ronald.

In: Blood Cells, Molecules and Diseases, Vol. 41, No. 3, 11.2008, p. 284-291.

Research output: Contribution to journalArticle

Sozer, Selcuk ; Wang, Xiaoli ; Zhang, Wei ; Fiel, Maria Isabel ; Ishii, Takefumi ; Wang, Jiapeng ; Wisch, Nathaniel ; Xu, Mingjiang ; Hoffman, Ronald. / Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders. In: Blood Cells, Molecules and Diseases. 2008 ; Vol. 41, No. 3. pp. 284-291.
@article{1442f5f541e84e89a32cefc0d9466351,
title = "Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders",
abstract = "The clinical course of patients with Philadelphia chromosome negative myeloproliferative disorder is frequently complicated by thrombotic events. Post-natal vasculogenesis has been proposed to play a critical role in angiogenesis by acting through a hierarchy of endothelial progenitor cells. Some endothelial progenitor cells have been shown to share a number of features associated with monocytes while other more primitive progenitor cells produce endothelial cells in vitro exclusively. The cells which share features of monocytes and endothelial cells have been termed angiogenic monocytes. Reduced levels of angiogenic monocyte progenitor cells have been reported to be predictive of atherosclerotic disease progression. Angiogenic monocyte progenitor cells were assayed in vitro from the peripheral blood mononuclear cells of myeloproliferative disorder patients. Angiogenic monocyte colonies were plucked and analyzed for endothelial cells and hematopoietic cell markers, JAK2V617F and their ability to incorporate into vascular endothelium following their transplantation into non-obese diabetic, severe combine immunodeficient mice. Myeloproliferative disorder angiogenic monocyte colonies that were detected were uniformly JAK2V617F positive and produced cells that expressed phenotypic markers characteristic of both monocytes and endothelial cells. Reduced numbers of angiogenic monocyte colonies were present in the blood of myeloproliferative disorder patients with a high JAK2V617F burden (> 50{\%}), (p <0.01). Transplanted angiogenic monocytes were able to contribute to the vascular endothelium of non-obese diabetic, severe combine immunodeficient mice. These studies suggest that reduced numbers of circulating angiogenic monocyte progenitors contribute to the propensity to develop thrombotic complications in myeloproliferative disorder patients.",
keywords = "Angiogenic monocytes, Endothelial cell, Myeloproliferative disorders, Thrombosis, Xenotransplant",
author = "Selcuk Sozer and Xiaoli Wang and Wei Zhang and Fiel, {Maria Isabel} and Takefumi Ishii and Jiapeng Wang and Nathaniel Wisch and Mingjiang Xu and Ronald Hoffman",
year = "2008",
month = "11",
doi = "10.1016/j.bcmd.2008.06.008",
language = "English (US)",
volume = "41",
pages = "284--291",
journal = "Blood Cells, Molecules, and Diseases",
issn = "1079-9796",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders

AU - Sozer, Selcuk

AU - Wang, Xiaoli

AU - Zhang, Wei

AU - Fiel, Maria Isabel

AU - Ishii, Takefumi

AU - Wang, Jiapeng

AU - Wisch, Nathaniel

AU - Xu, Mingjiang

AU - Hoffman, Ronald

PY - 2008/11

Y1 - 2008/11

N2 - The clinical course of patients with Philadelphia chromosome negative myeloproliferative disorder is frequently complicated by thrombotic events. Post-natal vasculogenesis has been proposed to play a critical role in angiogenesis by acting through a hierarchy of endothelial progenitor cells. Some endothelial progenitor cells have been shown to share a number of features associated with monocytes while other more primitive progenitor cells produce endothelial cells in vitro exclusively. The cells which share features of monocytes and endothelial cells have been termed angiogenic monocytes. Reduced levels of angiogenic monocyte progenitor cells have been reported to be predictive of atherosclerotic disease progression. Angiogenic monocyte progenitor cells were assayed in vitro from the peripheral blood mononuclear cells of myeloproliferative disorder patients. Angiogenic monocyte colonies were plucked and analyzed for endothelial cells and hematopoietic cell markers, JAK2V617F and their ability to incorporate into vascular endothelium following their transplantation into non-obese diabetic, severe combine immunodeficient mice. Myeloproliferative disorder angiogenic monocyte colonies that were detected were uniformly JAK2V617F positive and produced cells that expressed phenotypic markers characteristic of both monocytes and endothelial cells. Reduced numbers of angiogenic monocyte colonies were present in the blood of myeloproliferative disorder patients with a high JAK2V617F burden (> 50%), (p <0.01). Transplanted angiogenic monocytes were able to contribute to the vascular endothelium of non-obese diabetic, severe combine immunodeficient mice. These studies suggest that reduced numbers of circulating angiogenic monocyte progenitors contribute to the propensity to develop thrombotic complications in myeloproliferative disorder patients.

AB - The clinical course of patients with Philadelphia chromosome negative myeloproliferative disorder is frequently complicated by thrombotic events. Post-natal vasculogenesis has been proposed to play a critical role in angiogenesis by acting through a hierarchy of endothelial progenitor cells. Some endothelial progenitor cells have been shown to share a number of features associated with monocytes while other more primitive progenitor cells produce endothelial cells in vitro exclusively. The cells which share features of monocytes and endothelial cells have been termed angiogenic monocytes. Reduced levels of angiogenic monocyte progenitor cells have been reported to be predictive of atherosclerotic disease progression. Angiogenic monocyte progenitor cells were assayed in vitro from the peripheral blood mononuclear cells of myeloproliferative disorder patients. Angiogenic monocyte colonies were plucked and analyzed for endothelial cells and hematopoietic cell markers, JAK2V617F and their ability to incorporate into vascular endothelium following their transplantation into non-obese diabetic, severe combine immunodeficient mice. Myeloproliferative disorder angiogenic monocyte colonies that were detected were uniformly JAK2V617F positive and produced cells that expressed phenotypic markers characteristic of both monocytes and endothelial cells. Reduced numbers of angiogenic monocyte colonies were present in the blood of myeloproliferative disorder patients with a high JAK2V617F burden (> 50%), (p <0.01). Transplanted angiogenic monocytes were able to contribute to the vascular endothelium of non-obese diabetic, severe combine immunodeficient mice. These studies suggest that reduced numbers of circulating angiogenic monocyte progenitors contribute to the propensity to develop thrombotic complications in myeloproliferative disorder patients.

KW - Angiogenic monocytes

KW - Endothelial cell

KW - Myeloproliferative disorders

KW - Thrombosis

KW - Xenotransplant

UR - http://www.scopus.com/inward/record.url?scp=53449099681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53449099681&partnerID=8YFLogxK

U2 - 10.1016/j.bcmd.2008.06.008

DO - 10.1016/j.bcmd.2008.06.008

M3 - Article

VL - 41

SP - 284

EP - 291

JO - Blood Cells, Molecules, and Diseases

JF - Blood Cells, Molecules, and Diseases

SN - 1079-9796

IS - 3

ER -